全文获取类型
收费全文 | 2147998篇 |
免费 | 151160篇 |
国内免费 | 3979篇 |
专业分类
耳鼻咽喉 | 31568篇 |
儿科学 | 68223篇 |
妇产科学 | 60498篇 |
基础医学 | 303624篇 |
口腔科学 | 62997篇 |
临床医学 | 188142篇 |
内科学 | 410351篇 |
皮肤病学 | 48839篇 |
神经病学 | 168532篇 |
特种医学 | 84386篇 |
外国民族医学 | 595篇 |
外科学 | 327890篇 |
综合类 | 48702篇 |
现状与发展 | 7篇 |
一般理论 | 679篇 |
预防医学 | 153476篇 |
眼科学 | 51499篇 |
药学 | 165994篇 |
10篇 | |
中国医学 | 5074篇 |
肿瘤学 | 122051篇 |
出版年
2018年 | 20867篇 |
2016年 | 18690篇 |
2015年 | 20867篇 |
2014年 | 28968篇 |
2013年 | 43302篇 |
2012年 | 57911篇 |
2011年 | 61333篇 |
2010年 | 36230篇 |
2009年 | 34523篇 |
2008年 | 57706篇 |
2007年 | 62480篇 |
2006年 | 63326篇 |
2005年 | 60696篇 |
2004年 | 58708篇 |
2003年 | 56517篇 |
2002年 | 55140篇 |
2001年 | 104561篇 |
2000年 | 107348篇 |
1999年 | 90284篇 |
1998年 | 24100篇 |
1997年 | 21653篇 |
1996年 | 21148篇 |
1995年 | 19879篇 |
1994年 | 18449篇 |
1993年 | 17355篇 |
1992年 | 69502篇 |
1991年 | 67143篇 |
1990年 | 65996篇 |
1989年 | 64053篇 |
1988年 | 59065篇 |
1987年 | 57920篇 |
1986年 | 55233篇 |
1985年 | 52347篇 |
1984年 | 38925篇 |
1983年 | 33063篇 |
1982年 | 19310篇 |
1981年 | 17410篇 |
1979年 | 36705篇 |
1978年 | 25794篇 |
1977年 | 22634篇 |
1976年 | 20330篇 |
1975年 | 23070篇 |
1974年 | 27244篇 |
1973年 | 26573篇 |
1972年 | 25297篇 |
1971年 | 23682篇 |
1970年 | 22202篇 |
1969年 | 21356篇 |
1968年 | 19701篇 |
1967年 | 17650篇 |
排序方式: 共有10000条查询结果,搜索用时 15 毫秒
21.
卫逸涛肖惠敏谢银环孙丽军 《中华健康管理学杂志》2022,(8):547-552
目的了解老年人生命晚期获知疾病相关信息意向及影响因素。方法2016年10月至2017年6月,采用生命晚期疾病信息意向问卷,利用方便抽样法对福州市中心城区7所养老机构及15个社区的414例年龄≥60岁的老年人进行横断面调查,采用单因素分析、多元线性回归与有序多分类logistic回归分析老年人对疾病相关信息的需求水平、获知程度意向及其影响因素。结果414例老年人疾病相关信息需求得分为(17.1±4.9)分;48.8%(202/414)希望详尽知晓,30.7%(127/414)希望选择性了解,20.5%(85/414)不想知道任何信息;多元线性回归分析显示,年龄、文化程度、是否接受/见过其他生命维持治疗(LSTs)是影响老年人疾病相关信息需求水平的主要因素(标准化回归系数分别为-0.141、0.116、0.115,均P<0.05);有序多分类logistic分析显示,年龄(以60~69岁为参照,70~79岁:OR=0.544,95%CI:0.310~0.957;80~89岁:OR=0.526,95%CI:0.289~0.956)、文化程度(以小学及以下为参照,大专及以上:OR=2.166,95%CI:1.093~4.290)、主要生活费来源(以其他补贴为参照,家人支持:OR=7.303,95%CI:1.157~46.108;退休金:OR=9.288,95%CI:1.502~57.415;公积金/储蓄:OR=15.676,95%CI:2.122~115.793)、是否接受/见过其他LSTs(以是为参照,OR=1.985,95%CI:1.150~3.425)是影响老年人疾病相关信息获知程度意向的主要因素。结论老年人生命晚期获知疾病相关信息的意向程度较高,年龄、文化程度、主要生活费来源、是否接受/见过其他生命维持治疗等是其主要影响因素。 相似文献
22.
Purnima Gogoi Geetika Kaur Nikhlesh K Singh 《World journal of gastroenterology : WJG》2022,28(46):6497-6511
Colorectal cancer (CRC) is the third most diagnosed cancer and the second leading cause of cancer-related mortality in the United States. Across the globe, people in the age group older than 50 are at a higher risk of CRC. Genetic and environmental risk factors play a significant role in the development of CRC. If detected early, CRC is preventable and treatable. Currently, available screening methods and therapies for CRC treatment reduce the incidence rate among the population, but the micrometastasis of cancer may lead to recurrence. Therefore, the challenge is to develop an alternative therapy to overcome this complication. Nanotechnology plays a vital role in cancer treatment and offers targeted chemotherapies directly and selectively to cancer cells, with enhanced therapeutic efficacy. Additionally, nanotechnology elevates the chances of patient survival in comparison to traditional chemotherapies. The potential of nanoparticles includes that they may be used simultaneously for diagnosis and treatment. These exciting properties of nanoparticles have enticed researchers worldwide to unveil their use in early CRC detection and as effective treatment. This review discusses contemporary methods of CRC screening and therapies for CRC treatment, while the primary focus is on the theranostic approach of nanotechnology in CRC treatment and its prospects. In addition, this review aims to provide knowledge on the advancement of nanotechnology in CRC and as a starting point for researchers to think about new therapeutic approaches using nanotechnology. 相似文献
23.
24.
25.
Esin Benli Küçük Ercan Kaydok Kürsad Ramazan Zor Gamze Yıldırım Biçer 《Topics in stroke rehabilitation》2020,27(8):630-635
ABSTRACT Objective: Dry eye is reported to be associated with several neurological diseases. The aim of this study is to evaluate the patients with hemiplegia after stroke for dry eye and compare their results with a control group. Materials and methods: Forty-five patients with hemiplegia and 45 individuals as the control group were included in the study. Tear function tests (Schirmer and tear breakup time) and a dry eye questionnaire for dry eye symptoms (ocular surface disease index) were performed and the results of the two groups were compared. Results: Schirmer test results were significantly lower in the post-stroke hemiplegia group compared to the control group (11.3 ± 8.2 mm and 20.6 ± 11.6 mm, respectively, p < .001). Tear breakup time results were significantly lower in the post-stroke hemiplegia group compared to the control group (7.9 ± 3.1 s and 12.1 ± 4.3 s, respectively, p < .001). Ocular surface disease index scores were not significantly different between hemiplegia and control groups (21.6 ± 20.0 and 19.8 ± 13.9, respectively, p = .635). Schirmer scores lower than 10 mm (60% and 30%, p < .001) and tear breakup time results lower than 10 s (65.6% and 28.9%, p < .001) were also higher in the hemiplegia group compared to control group. Conclusion: We found lower Schirmer test and tear breakup time results and similar OSDI scores in hemiplegia patients compared to controls. Hemiplegia patients may have dry eye without typical symptoms. This should be taken into consideration in the follow-up and rehabilitation of post-stroke hemiplegia patients. 相似文献
26.
Brittney H. Cotta Margaret F. Meagher Aaron Bradshaw Stephen T. Ryan Gerant Rivera-Sanfeliz 《Expert review of anticancer therapy》2019,19(4):301-308
Introduction: Percutaneous renal mass biopsy has evolved over the last decade with improvements on previous pitfalls including low tissue yield, high non-diagnostic rates, and complications. As understanding of tumor biology and natural history of renal cortical neoplasms has improved, percutaneous renal mass biopsy is poised to have an expanding role in an area characterized by individualized management and refined risk stratification.
Areas covered: This review summarizes the evolution of renal mass biopsy to its current state with respect to outcomes, indications, and clinical guidelines.
Expert opinion: With improved understanding of differential biological potential of renal cortical neoplasms combined with technical improvements in diagnostic yield and accuracy, utilization of renal mass biopsy is becoming an important adjunct to patient care in a broad range of clinical scenarios, including active surveillance, thermal ablation, and use of primary systemic therapy in localized and advanced settings. 相似文献
27.
Tonya J.H. White 《Journal of the American Academy of Child and Adolescent Psychiatry》2019,58(11):1042-1050
28.
29.